• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Expert Rev Respir Med . Analysis of prediction and early warning indexes of patients with COVID-19

tetano

Editor, Senior Moderator
Expert Rev Respir Med


. 2020 Jul 23;1-4.
doi: 10.1080/17476348.2020.1793674. Online ahead of print.
Analysis of prediction and early warning indexes of patients with COVID-19


Lu Song[SUP] 1 [/SUP], Yongkang Dong[SUP] 2 [/SUP], Ming Xu[SUP] 3 [/SUP], Dongwu Shi[SUP] 1 [/SUP], Wei Guo[SUP] 4 [/SUP], Yaojun Li[SUP] 5 [/SUP], Xinri Zhang[SUP] 3 [/SUP], Xia Ma[SUP] 3 [/SUP]



Affiliations

Abstract

Background: The aim was to compare the laboratory data of patients with suspected and confirmed new coronavirus pneumonia (COVID-19) and look for diagnostic predictive and early warning indicators, which will help to better manage the disease.
Methods: A total of 36 confirmed COVID-19 patients were divided into the general (n = 17) and critical group (n = 19). The suspected group enrolled 23 suspected COVID-19 patients with the negative nucleic acid test result. We collected all patients' clinical characteristics and some laboratory indicators at the time of admission and conducted Logistic regression analysis after comparing the differences between groups.
Results: There were no significant differences in age, gender, disease duration, fever history, and comorbidities between the suspected and general group (P > 0.05); however, fibrinogen was statistically different (P < 0.05). Compared with the general group, the oxygenation index and lymphocytes were significantly reduced and the Neutrophil-to-lymphocyte Ratio (NLR) and total bilirubin were increased in the critical group (P < 0.05). The fibrinogen OR value was 2.52 (95% CI 1.18-5.36, P = 0.017) and the NLR OR value was 2.91 (95% CI 1.36-6.21, P = 0.006).
Conclusions: Fibrinogen is a valuable diagnostic predictor for patients with suspected COVID-19. For confirmed COVID-19 patients, the NLR is a valuable early warning indicator.

Keywords: Neutrophil-to-lymphocyte Ratio; New coronavirus; fibrinogen; pneumonia.
 
Back
Top Bottom